The GOS-Frail (Geriatric Oncology Supportive Care for Frail Older Adults With Cancer) Study

Launched by TAN TOCK SENG HOSPITAL · Aug 13, 2024

Keywords

ClinConnect Summary

The GOS-Frail study is a clinical trial designed to see how a special supportive care program can help improve the quality of life for older adults with cancer who are receiving treatment aimed at curing their disease. It focuses on patients aged 65 and older who have solid organ cancers, like those of the lungs, liver, or kidneys, and who are considered frail. Frailty is a condition that makes it harder for older adults to cope with illness and treatment. The study will compare two groups: one will attend a supportive clinic that offers tailored care and assistance, while the other will receive general educational materials about managing frailty.

To participate, individuals need to be at least 65 years old, have a diagnosis of solid organ cancer, and be scheduled for curative chemotherapy or radiotherapy. They also need to have a certain level of frailty, as measured by a clinical scale. Throughout the study, participants will fill out questionnaires about their quality of life at various times after starting treatment. This research could lead to better support for older adults undergoing cancer treatment, helping them to feel better and cope more effectively with their care.

Gender

ALL

Eligibility criteria

• • Inclusion criteria
• • 1. Age ≥ 65
• • 2. Diagnosis of solid organ cancer
• • 3. Plan for curative-intent chemotherapy and/or radiotherapy
• • 4. Clinical Frailty Scale (CFS) score ≥ 4,
• • Exclusion criteria: Evaluation by Geriatric or Palliative Medicine in the previous 6 months.